MedPath

雷允上药业集团有限公司

Ownership
-
Established
1994-03-31
Employees
-
Market Cap
-
Website
https://www.lys.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

84

NMPA:84

Drug Approvals

雷允上牌西洋参刺五加酸枣仁口服液

Approval Number
国食健注G20200492
Approval Date
Mar 16, 2022
NMPA

天蟾胶囊

Approval Number
国药准字Z20123030
Approval Date
Sep 9, 2021
NMPA

六神凝胶

Approval Number
国药准字Z20060460
Approval Date
Jul 5, 2021
NMPA

乌鸡白凤丸

Approval Number
国药准字Z20083415
Approval Date
Jan 14, 2021
NMPA

乌鸡白凤丸

Approval Number
国药准字Z20044012
Approval Date
Jan 14, 2021
NMPA

乌鸡白凤丸

Approval Number
国药准字Z32020549
Approval Date
Jan 14, 2021
NMPA

黄蛭益肾胶囊

Approval Number
国药准字Z20020086
Approval Date
Jan 14, 2021
NMPA

血尿胶囊

Approval Number
国药准字Z32020487
Approval Date
Sep 9, 2020
NMPA

口疳吹药

Approval Number
国药准字Z32020914
Approval Date
Sep 9, 2020
NMPA

吊筋药

Approval Number
国药准字Z32020486
Approval Date
Sep 9, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.